Salusins Promote Cardiomyocyte Growth but Does Not Affect Cardiac Function in Rats

Fang Yu,Jing Zhao,Jinghui Yang,Bin Gen,Shuheng Wang,Xing Feng,Chaoshu Tang,Lin Chang

DOI: https://doi.org/10.1016/j.regpep.2004.06.013

2004-01-01

Regulatory Peptides

Abstract:Salusin-α and -β are newly found polypeptides that stimulate proliferation, hypotension and bradycardia in vascular smooth muscle cells (VSMCs) and fibroblasts. Propresalusin mRNA is widespread, and positive stains for salusins have been observed in many human tissues such as endothelium and ventricular tissue. To investigate the bio-effect of salusins on cardiovascular function, 20 nmol/kg salusin-α or 2 nmol/kg salusin-β was intravenously (i.v.) injected into rats, and isolated rat hearts were perfused with 10−12 to 10−7 mol/l salusin-α or -β. 45Ca2+ uptake and 3H-Leucine incorporation were determined in cultured neonatal rat cardiomyocytes. Neither salusin-a nor -β affected cardiac function in vivo or in vitro but salusin-β decreased mean arterial blood pressure (MAP). The polypeptides' stimulation of 45Ca2+ uptake and 3H-Leucine incorporation was concentration-dependent, and the incorporation was inhibited by nicardipine (Nic) and FK-506 [FK; an inhibitor of calcineurin (CaN)]. PD98059 [PD; inhibitor of mitogen-activated protein kinase (MAPK)] and chelerythrine [inhibitor of protein kinase C (PKC)] inhibited salusin-stimulated 3H-Leucine incorporation. Endothelin-1 (ET) synergistically increased salusin-induced 45Ca2+ uptake. Our results suggest that salusin-α and -β did not directly affect cardiac function in the rat heart but that they improved calcium uptake and protein synthesis in neonatal rat cardiomyocytes through the calcium, calcineurin, MAPK and PKC signal pathways. Salusins may be regulatory factors for myocardial growth and hypertrophy.